<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Hemolytic Anemia - Hereditary Sperocytosis</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`üß† Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Hemolytic Anemia - Hereditary Sperocytosis</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                16 Questions | 16 Total Marks | 26 min Duration | ~97.5 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 16 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 26 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 16</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Hemolytic Anemia - Hereditary Sperocytosis - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 16</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 16 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A 10-year-old male child presents with easy fatigability and jaundice for the last 1 month. had similar episodes in the past. On examination, he is found to have splenomegaly. MCHC is 44 g/dl. On ultrasound examination, he is found to have gallstones. Which of the following statements is false regarding this condition?", "options": [{"label": "A", "text": "Severe forms are inherited in an autosomal recessive manner", "correct": false}, {"label": "B", "text": "ANK-1 mutations account for the majority of this condition", "correct": false}, {"label": "C", "text": "SLC2A1 mutations are associated with ovalocytosis and cause cardiovascular severe complications", "correct": true}, {"label": "D", "text": "All the above statements are true", "correct": false}], "correct_answer": "C. SLC2A1 mutations are associated with ovalocytosis and cause cardiovascular severe complications", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>SLC2A1 mutations are associated with ovalocytosis and cause cardiovascular severe complications The clinical features and history are suggestive of hereditary spherocytosis(HS) . Points favoring diagnosis -Presentation of a child with anemia, jaundice and splenomegaly is indicative of a congenital hemolytic anemia elevated MCHC is a significant point in favor of the clinical diagnosis The presence of gallstones should trigger suspicion of Hereditary spherocytosis. mutations of the SLC2A1 gene(mutation in GLUT1 Glucose transporter) on Chr 1p34 leads to overhydrated hereditary stomatocytosis and is associated with severe neurological manifestations</p>\n<p><strong>Highyeild:</strong></p><p>Mutation in ANKYRIN, Band 3 ‚Äì spherocytosis Mutation in Band 3‚Äìovalocytosis Mutation in Spectrin‚ÄìElliptocytosis</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. It has been recognised that the inheritance of HS is not always Autosomal dominant, and some of the most severe forms are Autosomal recessive. Ankyrin and Band 3 mutations ‚ÄìAutosomal dominant form of hereditary spherocytosis. Spectrin Band 4.2 mutations ‚ÄìAutosomal dominant form of Hereditary Spherocytosis. Option: B. ANK-1 gene mutations that code for Ankyrin may account for most HS.</p>\n<p><strong>Extraedge:</strong></p><p>A classification for HS has been developed based on the severity of anemia and markers of hemolysis (reticulocyte count and bilirubin) HS trait ‚Äì Normal hemoglobin, bilirubin, and reticulocyte count Mild HS (20 to 30 percent of cases) ‚Äì Hemoglobin 11 to 15 g/dL; reticulocytes 3 to 6 percent; bilirubin 1 to 2 mg/dL (from 17 to 34 micromol/L) Moderate HS (60 to 75 percent of cases) ‚Äì Hemoglobin 8 to 12 g/dL; reticulocytes >6 per cent; bilirubin >2 mg/dL (>34 micromol/L) Severe HS (5 per cent of cases) ‚Äì Hemoglobin 6 to 8 g/dL; reticulocytes >10 per cent; bilirubin >3 mg/dL (>51 micromol/L)</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 41-year-old male presents to medicine OPD, distressed that he ‚Äúpassed blood instead of urine‚Äù yesterday. CBC done showed pancytopenia. LDH is 1100 IU/L. Haptoglobin is undetectable. Direct and indirect Coombs test is negative Treatment of this condition is?", "options": [{"label": "A", "text": "Eculizumab", "correct": true}, {"label": "B", "text": "Long term corticosteroids", "correct": false}, {"label": "C", "text": "Azathioprine+ATG", "correct": false}, {"label": "D", "text": "Alemtuzumab", "correct": false}], "correct_answer": "A. Eculizumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Eculizumab The patient has presented hemoglobinuria and features of haemolytic anemia. DCT is negative He also has pancytopenia and elevated LDH . All these findings make the diagnosis of Paroxysmal Nocturnal Hemoglobinuria compelling. Treatment of PNH:- Long-term hemolysis glucocorticoids are not indicated as they do not affect chronic hemolysis. They are contraindicated as their side effects are considerable. Short-term prednisone may be helpful when an inflammatory process exacerbates hemolysis. Best treatment = Bone marrow transplantation. The best treatment to prevent chronic hemolysis or clot formation = Eculizumab Eculizumab is a monoclonal antibody that specifically binds to the complement protein C5, thus inhibiting terminal complement-mediated intravascular hemolysis in PNH patients. The only treatment that currently can provide a definitive cure for PNH is allogeneic bone marrow transplantation (BMT).</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Options: B, C & D are not the correct options for treatment in PNH.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which doesn‚Äôt cause hemolysis in G6PD deficiency?", "options": [{"label": "A", "text": "Oestrogen", "correct": true}, {"label": "B", "text": "Salicylates", "correct": false}, {"label": "C", "text": "Primaquine", "correct": false}, {"label": "D", "text": "Nitrofurantoin", "correct": false}], "correct_answer": "A. Oestrogen", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Oestrogen G6PD deficiency is the most common enzymopathy. G6PD enzyme is required to convert glucose 6 phosphate to 6 phosphogluconolactone , producing This is required to keep Glutathione in the reduced state to prevent oxygen damage to the RBC. X-linked inheritance. Most common in males. Females are affected when both X chromosomes are involved(rare) Hemolysis can be triggered due to three reasons in G6PD deficiency patients. 1) fava beans, (2) infections, and (3) drugs. The following drugs carry the risk of clinical hemolysis in G6PD-deficient individuals. Acute G6PD deficiency occurs within 2-4 days of inciting agent. Patients present with high-coloured urine and abdominal pain. Drugs That Carry Risk of Clinical Hemolysis in Persons with Glucose 6-Phosphate Dehydrogenase Deficiency DEFINITE RISK POSSIBLE RISK DOUBTFUL RISK Antimalarials Primaquine Dapsonel chlorproguanil* Chloroquine; hydroxychloroquine Quinine Sulphonamides/ sulphones Dapsone Sulfamethoxazole Sulfasalazine Sulfadimidine Sulfisoxazole Sulfadiazine Antibacterial/ antibiotics Cotrimoxazole Nalidixic acid Nitrofurantoin Niridazole Ciprofloxacin Norfloxacin Chloramphenicol p-Aminosalicylic acid Antipyretic/ analgesics Acetanilide Phenazopyridine Acetylsalicylic acid high dose (>3 g/d) Acetaminophen Phenacetin Other Rasburicase Naphthalene Methylene blue Vitamin K analogues Ascorbic acid (>1 g) Doxorubicin Probenecid</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 43-year-old male suddenly passed out blood instead of urine. Routine check-ups revealed he had anemia. After some days of deteriorating conditions, he was diagnosed with acute hepatomegaly. Further blood tests revealed liver function tests are normal. What will you do next?", "options": [{"label": "A", "text": "Allogeneic bone marrow transplantation", "correct": false}, {"label": "B", "text": "Continue supportive treatment", "correct": false}, {"label": "C", "text": "Eculizumab", "correct": true}, {"label": "D", "text": "Long term glucocorticoids", "correct": false}], "correct_answer": "C. Eculizumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Eculizumab Eculizumab and Ravulizumab are monoclonal antibodies against c5 used in the treatment of paroxysmal nocturnal hemoglobinuria. The clinical symptom of sudden onset blood instead of urine and the diagnosis of acute hepatomegaly with no underlying liver disease suggest PNH (paroxysmal nocturnal hemoglobinuria). Intracorpuscular acquired cause of intravascular hemolysis. Patients generally present with episodic early morning Hematuria. A significant advancement in treating this disease is the introduction of a monoclonal antibody Eculizumab in 2007. This antibody binds to the complement component c5 near the site that, when cleaved, will trigger the formation of the MAC. With the c5 blocked, there is no intravascular hemolysis. Hence for many PNH patients, Eculizumab is a real improvement in quality of life with reduced associated complications, especially thrombosis. A. Allogenic BMT This is a definitive cure with the cost of non-negligible risks, but the latter is more effective after the discovery of Eculizumab in 2007. B. Continue supportive treatment This is required for patients who cannot afford Eculizumab because it is expensive and accessible in many parts of the world. D. Long term glucocorticoids Not indicated because there is no evidence that it has any effect on chronic hemolysis.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "The patient with von Willebrand disease is about to undergo a root canal procedure. What should be done?", "options": [{"label": "A", "text": "E-aminocaproic acid", "correct": false}, {"label": "B", "text": "Desmopressin", "correct": true}, {"label": "C", "text": "Vwf replacement", "correct": false}, {"label": "D", "text": "Tranexamic acid", "correct": false}], "correct_answer": "B. Desmopressin", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Desmopressin Von Willebrand disease is the most common inherited bleeding disorder. It is due to a deficiency of VWF. The mainstay of treatment in VWD is ddavp (desmopressin). can be given intravenously or intranasally. It is recommended for patients with VWD. Ddavp can be tested in the laboratory for their response; in patients who respond well, it can be used in procedures with minor to moderate risk of bleeding, like before root canal surgery or any dental procedures</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A- This is an antifibrinolytic drug, next in line after ddavp and is used to prevent mucosal bleeding. It is contraindicated in the setting of upper urethral bleeding due to the risk of urethral obstruction. Option: C- Used for major procedures and not in minor procedures like dental procedures. Option: D- This is an antifibrinolytic drug next in line after ddavp. It is used to prevent mucosal bleeding, particularly useful in treating heavy menstrual bleeding (TXA 1300 mg every 8 h) and postpartum hemorrhage.</p>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 22-year-old primigravida in the first trimester presents with extreme fatigue, pallor, and icterus. She reports being previously healthy. On evaluation, her hemoglobin is 8 g/dL with a normal MCV and an elevated MCHC, reticulocyte count is 9%, indirect bilirubin is 4.9 mg/dL, and serum haptoglobin is not detectable. Her peripheral smear is shown in the image. Her physical examination is notable for splenomegaly and a normal 3-month uterus. What is the most likely diagnosis?", "options": [{"label": "A", "text": "Colonic polyp", "correct": false}, {"label": "B", "text": "G6PD deficiency", "correct": false}, {"label": "C", "text": "Hereditary spherocytosis", "correct": true}, {"label": "D", "text": "Parvovirus B19 infection", "correct": false}], "correct_answer": "C. Hereditary spherocytosis", "question_images": ["https://dbmi-data.s3.ap-south-1.amazonaws.com/photos-1684542583693-QTDM080007IMG1.JPG"], "explanation_images": [], "explanation": "<p><strong>Solution:</strong></p><p>Hereditary spherocytosis The peripheral blood smear shows micro spherocytes, small densely staining red blood cells that have lost their central pallor characteristic of hereditary spherocytosis. Spherocytosis is almost the only condition with an increased mean corpuscular hemoglobin concentration (MCHC). Hereditary spherocytosis is a heterogeneous RBC membranopathy that can be either congenital (usually autosomal dominant ) or acquired; it is characterised by predominantly extravascular hemolysis in the spleen caused by defects in membrane structural proteins. This spleen-mediated hemolysis leads to converting classic biconcave RBCs on smear to spherocytes. Splenomegaly is common. Acute treatment is with transfusion.</p>\n<p><strong>Random:</strong></p><p>Explanation For Incorrect Options:- Option: A. Chronic gastrointestinal blood loss, such as caused by a colonic polyp, would cause microcytic, hypochromic anemia without evidence of hemolysis (indirect bilirubin, haptoglobin abnormalities). Option: B. Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a cause of hemolysis usually triggered by an offending oxidative agent. peripheral blood smear may show Heinz